Come up with a name for your new list and we'll add to it:
Oncorus raised a round of funding on December 15, 2016. Investors include
Astellas Venture Management.
Oncorus is an early-stage biotechnology company developing a next-generation immunotherapy platform of oncolytic viruses to treat several types of cancer, including highly malignant and aggressive can…